About CME E-mini NASDAQ Biotechnology Futures

Contract Size
The size of one CME E-mini^® NASDAQ^® Biotechnology futures contract equals $50 (the contract’s multiplier) times the current CME E-mini NASDAQ Biotechnology futures level. The contract moves in ticks of 0.10 index points valued at $5.00 per contract (futures calendar spreads move in increments of 0.05 index points = $2.50 contract).

CME E-mini NASDAQ Biotechnology futures expire on a quarterly basis and are listed two months out in the March quarterly cycle. These contracts trade electronically only on the CME Globex^® platform nearly 24 hours a day around the clock, around the world.

Underlying Index
The NASDAQ Biotechnology Index is one of the most frequently quoted benchmarks for measuring performance of biotechnology companies. The Index tracks approximately 150 companies that have been classified by the FTSE™ Global Classification System as either biotechnology or pharmaceutical, and have met other eligibility criteria set by NASDAQ for inclusion in the Index. Biotechnology firms continue to attract a huge infusion of capital. For investors, determining the companies in which to invest – those best-positioned to overcome regulatory hurdles and other resource challenges to get an innovative product to market on time – is not that simple, and can be risky. The NASDAQ Biotechnology Index gives investors a performance measurement they can use to help evaluate companies before they invest

For a complete list of stocks in the index and Index methodology, visit the NASDAQ Web Site.